IRCT20161121031003N4尚未招募2 期
A clinical trial to compare the effect of rivaroxaban with enoxaparin on the prophylaxis of venous thromboembolism in patients undergoing knee or hip arthroplasty surgery.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •More than 18 years of age
- •Who are candidate for hip or knee arthroplasty surgery
排除标准
- •Severe side effects of a drug
- •Moderate to severe hepatic disorder
- •Cardiovascular diseases
研究者
相似试验
招募中
2 期
The effect of rivaroxaban on hearing lossDecreased sensorineural hearing.Unspecified sensorineural hearing lossH90.5IRCT20110603006699N5Esfahan University of Medical Sciences34
已完成
不适用
A randomised controlled trial with rivaroxaban and apixaban in the treatment for venous thromboembolism in cancer patientsVenous thromboembolism with cancer patientsJPRN-UMIN000026600Chiba Cancer Center100
招募中
2 期
Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgeryChronic Thrombo Embolic Pulmonary Hypertension(CTEPH).Chronic Thromboembolic Pulmonary Hypertension.I27. 24IRCT20151227025726N22Shahid Beheshti University of Medical Sciences96
招募中
2 期
Treatment with rivaroxaban compared with warfarin in patients with acute coronary syndromeAcute coronary syndrome.Other acute ischemic heart diseasesIRCT20210614051574N9Esfahan University of Medical Sciences60
招募中
2 期
Anticoagulant therapy for cancer-associated blood clotsCancer-associated thrombosisDeep Vein ThrombosisPulmonary EmbolismVenous ThromboembolismACTRN12617000331336South East Sydney and Illawarra Area Health Service600